Studies in prostate cancer have also shown that TF expression was significantly higher in prostate cancer cells than benign prostatic epithelium and correlates significantly with Gleason score and stage of disease, the expression of VEGF-A, higher micro-vessel density, bone metastases and poor survival [11], [31]–[33]. The gene discussed is VEGFA; the disease is prostate cancer.